This paper highlights the synergistic potential of combining saponin-based ISCOM adjuvants with immune regulatory modulation, specifically transient depletion of CD25+ regulatory T cells, to enhance influenza vaccine responses in aged mice.  The study demonstrates that while ISCOMs alone significantly boost antibody titers and protection, their effectiveness is further amplified when paired with targeted CD25+ cell […]

This study evaluates the immunogenicity and protective efficacy of a recombinant H5 hemagglutinin (HA) nanoparticle vaccine adjuvanted with Matrix-M, administered either intranasally or intramuscularly, against a highly pathogenic clade 2.3.4.4b H5N1 influenza virus in mice.  The research demonstrates that both routes induce robust systemic and mucosal antibody responses, including neutralizing antibodies, and confer complete protection […]

This paper explores how rapid boosting strategies can significantly enhance germinal center (GC) responses in the context of HIV vaccination, particularly emphasizing the role of saponin-based adjuvants.  Utilizing a mouse model, the researchers demonstrate that quick homologous or heterologous reimmunizations amid ongoing GCs lead to robust expansion and evolution of B cells targeting HIV Env, […]

This paper uniquely explores how the adjuvant AS01 enhances immune responses in aged populations, focusing on its role in overcoming immunosenescence. By comparing responses to the herpes zoster vaccine (RZV) with those of the inactivated influenza vaccine (IIV4), the study reveals that RZV, equipped with AS01, induces robust humoral and cellular immunity, including polyfunctional CD4+ […]

This paper presents the design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01E-4 tuberculosis vaccine, which incorporates the AS01 adjuvant system. The primary focus is on evaluating vaccine efficacy in IGRA-positive, HIV-negative adults to highlight the strategic enrichment of high-risk populations for efficient detection of protective effects. The study also emphasizes […]

This paper offers a comprehensive overview of next-generation vaccine adjuvants, with particular emphasis on nanotechnology, systems immunology, and computational approaches. The review systematically connects the immunological mechanisms of adjuvants with their physicochemical properties, delivery platforms, and clinical applications, illustrating how advances in nanotechnology and systems biology can optimize their efficacy and safety.  The background of […]

This paper provides a comprehensive overview of advanced nanoparticle-based vaccine platforms, including a focused emphasis on saponin-derived self-assembling nanoplatforms such as ISCOMs and Matrix-M. It highlights how these natural amphiphilic saponins intrinsically possess both delivery and immunostimulatory functions, effectively acting as adjuvants that promote robust humoral and cellular immune responses, including cross-presentation and mucosal immunity.  […]

This paper is a significant contribution to the field of saponin-based adjuvants, particularly highlighting the potent immunostimulatory capacity of the saponin-MPLA nanoparticle adjuvant (SMNP) compared to MPLA alone. It demonstrates that SMNP, by combining TLR4 activation with inflammasome stimulation through saponin components like QS-21, elicits a more robust cytokine response and can indirectly reverse HIV-1 […]